These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21761955)

  • 1. Osteoporosis and the burden of osteoporosis-related fractures.
    Dempster DW
    Am J Manag Care; 2011 May; 17 Suppl 6():S164-9. PubMed ID: 21761955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world challenges of treating osteoporosis.
    Owens G
    Am J Manag Care; 2011 May; 17 Suppl 6():S177-84. PubMed ID: 21882487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation.
    Ray NF; Chan JK; Thamer M; Melton LJ
    J Bone Miner Res; 1997 Jan; 12(1):24-35. PubMed ID: 9240722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification, diagnosis, and prevention of osteoporosis.
    Levine JP
    Am J Manag Care; 2011 May; 17 Suppl 6():S170-6. PubMed ID: 21761956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial.
    Montori VM; Shah ND; Pencille LJ; Branda ME; Van Houten HK; Swiglo BA; Kesman RL; Tulledge-Scheitel SM; Jaeger TM; Johnson RE; Bartel GA; Melton LJ; Wermers RA
    Am J Med; 2011 Jun; 124(6):549-56. PubMed ID: 21605732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Education and information: important tools in assessing the risks and prevention of osteoporosis fractures.
    Ceausu I
    Climacteric; 2010 Dec; 13(6):530-3. PubMed ID: 20690867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.
    Burge R; Dawson-Hughes B; Solomon DH; Wong JB; King A; Tosteson A
    J Bone Miner Res; 2007 Mar; 22(3):465-75. PubMed ID: 17144789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of incident vertebral and non-vertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: results from the teriparatide randomized, placebo-controlled trial in postmenopausal women.
    Oglesby AK; Minshall ME; Shen W; Xie S; Silverman SL
    J Rheumatol; 2003 Jul; 30(7):1579-83. PubMed ID: 12858462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summaries for patients: Osteoporosis treatment based on a woman's probability of fracture.
    Ann Intern Med; 2010 Nov; 153(9):I62. PubMed ID: 21041573
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteoporosis overview.
    Peterson JA
    Geriatr Nurs; 2001; 22(1):17-21; quiz 22-3. PubMed ID: 11223792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.
    Salaffi F; Cimmino MA; Malavolta N; Carotti M; Di Matteo L; Scendoni P; Grassi W;
    J Rheumatol; 2007 Jul; 34(7):1551-60. PubMed ID: 17516618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between duration of compliant bisphosphonate use and the risk of osteoporotic fractures .
    Meijer WM; Penning-van Beest FJ; Olson M; Herings RM
    Curr Med Res Opin; 2008 Nov; 24(11):3217-22. PubMed ID: 18922215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient management of the elderly patient following fragility hip fracture.
    Sanders S; Geraci SA
    Am J Med; 2011 May; 124(5):408-10. PubMed ID: 21531228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [FRAX--model for 10-year fracture risk assessment. Support in the treatment of osteoporosis, according to preliminary Swedish guidelines].
    Johansson H; Kanis JA; Ljunggren O; Ström O; Svensson O; Mellström D
    Lakartidningen; 2011 Feb 16-22; 108(7):336-9. PubMed ID: 21539116
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of postmenopausal osteoporosis.
    Murphy FT; Kivitz AJ; Sands EE
    J Am Osteopath Assoc; 2003 Oct; 103(10 Suppl 6):S6-11. PubMed ID: 14620079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current controversies in clinical management of postmenopausal osteoporosis.
    Kerschan-Schindl K; Mikosch P; Obermayer-Pietsch B; Gasser RW; Dimai HP; Fahrleitner-Pammer A; Dobnig H; Roschger P; Preisinger E; Klaushofer K; Resch H; Pietschmann P
    Exp Clin Endocrinol Diabetes; 2014 Sep; 122(8):437-44. PubMed ID: 24838156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of osteoporosis and its economic aspects].
    Blachier C
    Cah Sociol Demogr Med; 1999; 39(2-3):271-82. PubMed ID: 10615567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.